NewAmsterdam Pharma Company had a revenue of 19.14M in the quarter ending Jun 30, 2025, with 542.88%. This bring the company's revenue in the last twelve months to 64.01M, Decreased 35.78%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 257.00% growth.